NewEdge Advisors’s GoodRx Holdings GDRX Stock Holding History

NewEdge Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-233	Closed	-$1.09K	–	3702
2022 Q4	$1.09K	Buy	+233	New	+$1.15K	﹤0.01%	3015
2021 Q3	–	Sell	-32,621	Closed	-$1.17M	–	1168
2021 Q2	$1.17M	Sell	32,621 -18,997	-37%	-$701K	0.03%	452
2021 Q1	$2.01M	Buy	51,618 +39,382	+322%	+$1.77M	0.06%	286
2020 Q4	$494K	Buy	+12,236	New	+$562K	0.02%	626

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewEdge Advisors's GDRX Position: Q1 2023 in Review

NewEdge Advisors sold out of GoodRx Holdings (GDRX) in Q1 2023, closing a stake of 233 shares — an estimated $1.09K sold.

NewEdge Advisors first reported a position in GDRX in Q4 2020 and held it in 4 quarters. The position peaked at $2.01M in Q1 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

NewEdge Advisors reported no remaining GoodRx Holdings position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 233 GoodRx Holdings shares in Q1 2023, an estimated $1.09K.
NewEdge Advisors first reported a position in GoodRx Holdings in Q4 2020 and held it in 4 quarters.
NewEdge Advisors's GoodRx Holdings position peaked at $2.01M in Q1 2021.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.